Kindred Biosciences Inc 's ability to collect accounts receivable sequentially worsen to 2.03, indicating more challenging environment then in the first quarter 2021, but still, it is a far cry from any concerns. Kindred Biosciences Inc 's Accounts Receivable average collection period in the Jun 30 2021 quarter, has increased to 180 days, from 30 days, in the Mar 31 2021 quarter.

If we take a look into Healthcare sector 492 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2021 from 3385 to 3414.

What is Receivable Turnover Ratio?
What is Kindred Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KIN Receivables Turnover Ratio	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter
Y / Y Receivable Change	491.25 %	5111.07 %	-32.39 %	-7.74 %	-71.93 %
Y / Y Revenue Change	-91.06 %	297.18 %	-32.12 %	-5.53 %	3101.21 %
Receivable Turnover Ratio (TTM)	2.03	12.26	90.19	78.59	76.51
KIN's Total Ranking	# 3414	# 3385	# 3385	# 3526	# 3382
Accounts Receivable average collection period days	180	30	4	5	5
Seq. Receivable Change	-87.77 %	1937.66 %	-15.56 %	180.99 %	7.79 %
Seq. Revenue Change	47.68 %	151.84 %	-8.82 %	-97.36 %	6461.69 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 186
Healthcare Sector	# 493
Overall Market	# 3414

Receivable Turnover Ratio Statistics
High	Average	Low
0.41	0.2	0.03
(Mar 31 2021)		(Jun 30 2019)

KIN Company Profile • Back to KIN Efficiency Comparisons • Compare KIN Receivables Turnover Ratio to its Competitors

Financial Statements
Kindred Biosciences Inc 's Accounts Receivable	$ 2 Millions	Visit KIN's Balance sheet
Kindred Biosciences Inc 's Sales TTM	$ 8 Millions	Visit KIN's Income Statement
Sources of KIN's Revenues		Visit KIN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KIN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KIN's Growth Rates	KIN's Roa	KIN's Inventory Turnover Ratio	KIN's Dividend Comparisons
KIN's Profitability Ratios	KIN's Roi	KIN's Asset Turnover Ratio	KIN's Dividend Growth
KIN's Valuation Ratios	KIN's Roe	KIN's Financial Strength Ratios	KIN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2021	Receivable at quarter ending Jun 30 2021
Corcept Therapeutics Inc	14.01	$ 343.087 Millions	$ 24.494 Millions
Cytokinetics Incorporated	13.93	$ 57.801 Millions	$ 4.150 Millions
Lexicon Pharmaceuticals Inc	13.92	$ 7.094 Millions	$ 0.510 Millions
Timber Pharmaceuticals Inc	13.92	$ 0.883 Millions	$ 0.063 Millions
Beone Medicines Ltd	13.60	$ 947.044 Millions	$ 69.617 Millions
International Stem Cell Corporation	13.60	$ 6.447 Millions	$ 0.474 Millions
Bridgebio Pharma Inc	13.46	$ 62.735 Millions	$ 4.659 Millions
Semler Scientific inc	13.05	$ 50.294 Millions	$ 3.853 Millions
Escalon Medical Corp	12.76	$ 10.472 Millions	$ 0.821 Millions
Pulmatrix Inc	12.70	$ 10.016 Millions	$ 0.789 Millions
Eargo Inc	12.63	$ 85.495 Millions	$ 6.767 Millions
La Jolla Pharmaceutical Company	12.48	$ 70.219 Millions	$ 5.628 Millions
Emmaus Life Sciences Inc	12.37	$ 23.677 Millions	$ 1.914 Millions
Rockwell Medical inc	12.06	$ 61.054 Millions	$ 5.063 Millions
Cano Health Inc	11.93	$ 393.163 Millions	$ 32.958 Millions
Morphic Holding inc	11.91	$ 38.771 Millions	$ 3.256 Millions
Conformis inc	11.90	$ 103.001 Millions	$ 8.655 Millions
Clene Inc	11.82	$ 0.201 Millions	$ 0.017 Millions
Therapeutic Solutions International Inc	11.82	$ 0.074 Millions	$ 0.006 Millions
Integrated Biopharma Inc	11.76	$ 63.559 Millions	$ 5.406 Millions
Alpha Pro Tech Ltd	11.73	$ 100.013 Millions	$ 8.527 Millions
Kushco Holdings Inc	11.69	$ 114.640 Millions	$ 9.808 Millions
Chembio Diagnostics Inc	11.61	$ 35.686 Millions	$ 3.073 Millions
Cidara Therapeutics Inc	11.55	$ 41.416 Millions	$ 3.586 Millions
Aim Immunotech Inc	11.48	$ 21.870 Millions	$ 1.906 Millions
Strongbridge Biopharma plc	11.46	$ 34.721 Millions	$ 3.031 Millions
Teladoc Health Inc	11.43	$ 1,486.656 Millions	$ 130.121 Millions
Esperion Therapeutics Inc	11.37	$ 62.108 Millions	$ 5.464 Millions
Scienture Holdings Inc	11.28	$ 13.278 Millions	$ 1.177 Millions
Vaso Corporation	11.28	$ 68.877 Millions	$ 6.108 Millions

Date modified: 2026-08-29T17:19:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.